U.S. Medical Equipment Stock News

Atlas Energy Solutions recently expanded its autonomous truck operations in the Permian Basin with Kodiak AI, adding a second load-out point along its 42-mile Dune Express conveyor and planning to grow its Kodiak-enabled fleet from 28 to 100 driverless trucks by mid-2027, including operations on public roads subject to milestones. This move highlights how Atlas is using automation to extend its geographic reach, integrate mining and logistics, and potentially lower operational complexity,...

Leadership shake up at Fermi following new executive appointments Fermi (FRMI) has drawn fresh investor attention after its board appointed a new Chief Financial Officer, General Counsel, Chief Commercial Officer, and Chief Operating Officer, all effective as of July 22, 2026. See our latest analysis for Fermi. Fermi's short term share price return has come under pressure, with the stock down 15.45% over one day, 23.11% over seven days, and 33.22% over 30 days. However, the 90 day share price...

Leadership transition at Cabot puts succession planning in focus Cabot (CBT) has announced that long-serving President and CEO Sean Keohane will retire in late 2026, with current CFO and Head of Corporate Strategy Erica McLaughlin set to assume the top role. This planned handover, paired with Keohane’s advisory role through year end 2026, gives investors time to assess how McLaughlin’s background in finance and operations might shape expectations for the stock. See our latest analysis for...

Compañía de Minas Buenaventura S.A.A. reported past second-quarter 2026 results with revenue of US$528.99 million and net income of US$237.36 million, while basic earnings per share reached US$0.93, all higher than the same period a year earlier. Over the first half of 2026, the company’s revenue rose to US$1.15 billion and net income to US$513.99 million, highlighting stronger profitability that may influence how investors view its longer-term earnings profile. We will now examine how this...

Tsakos Energy Navigation Ltd. recently took delivery of the DP2 suezmax shuttle tanker “Anfield DP” from Samsung Heavy Industries in South Korea, the third in a planned series of 12 vessels, which has begun a 10‑year charter with a US oil major and extension options up to its 20th year. This delivery deepens Tsakos Energy Navigation’s presence in Brazil’s high-barrier offshore market and contributes to a long-term charter backlog supporting approximately US$3.50 billion in minimum gross...

Why Morgan Stanley Is Back in Focus for Stock Investors Morgan Stanley (MS) is under fresh scrutiny after reports that bankers were pressured to approve mortgages for wealthy clients, while the company is also active in the bond market and pursuing a large open-ended share buyback. See our latest analysis for Morgan Stanley. Morgan Stanley’s recent headlines around internal mortgage practices and fresh bond issuance come after a strong run, with the share price returning 15.68% year to date...

Cushman & Wakefield recently expanded its National Industrial Advisory Group by appointing former JLL advisor Melinda Marino as Managing Director in Northern California, while also arranging the off‑market US$32,000,000 all‑cash 1031 exchange acquisition of Royal Oaks, a 69‑unit townhome community in Hollywood, Florida at a record price per unit and a sub‑5% cap rate. Together with new research underscoring power and permitting constraints in global data centre expansion, these developments...

Esquire Financial Holdings, Inc. reported second‑quarter 2026 results showing higher net interest income of US$35.75 million and net income of US$12.98 million year on year, and it subsequently paid a regular quarterly dividend of US$0.20 per share on September 1, 2026 to stockholders of record on August 14, 2026. The combination of rising net interest income and earnings, alongside the continuation of the regular dividend, underlines management’s emphasis on consistent profitability and...

In July 2026, The Chefs' Warehouse, Inc. reported second-quarter results showing higher year-over-year sales of US$1,168.61 million and net income of US$33.77 million, and issued full-year 2026 net sales guidance of US$4.50–4.60 billion. The combination of stronger quarterly profitability and higher full-year sales expectations highlighted the company’s progress in scaling its premium foodservice model while improving earnings. We’ll now examine how this stronger second-quarter performance...

Balchem Corporation has reported its second-quarter and half-year 2026 results, with Q2 sales of US$284 million and net income of US$44.62 million, alongside six-month sales of US$554.71 million and net income of US$84.9 million, all higher than the same periods a year earlier. The company’s rising basic and diluted earnings per share from continuing operations for both the quarter and year-to-date periods highlight improving profitability and operating leverage across its portfolio. With...

Impinj (PI) is in focus after reporting second quarter 2026 results and issuing fresh guidance for the third quarter, giving investors new data on both recent performance and near term expectations. See our latest analysis for Impinj. The latest earnings and guidance appear to have sharpened focus on Impinj, with the share price at $151.36 after a 7 day share price return of 18.67%, while the year to date share price return is down 15.80% and the 3 year total shareholder return is up 149.28%...

Restructuring puts monday.com stock under the spotlight monday.com (NasdaqGS:MNDY) is in focus after launching a restructuring plan that cuts about 20% of its workforce and prioritizes its AI Work Platform, while also reiterating 2026 revenue growth guidance of 19% to 20%. See our latest analysis for monday.com. The restructuring headline has arrived after a strong short term rebound in monday.com’s share price, with a 19.81% 90 day share price return. However, longer term total shareholder...

In late July 2026, Strategic Education, Inc. reported higher second-quarter and first-half sales and earnings, completed a long-running share repurchase program totaling about US$987.9 million for 9,264,442 shares, and declared a regular quarterly dividend of US$0.60 per share payable on September 14, 2026 to shareholders of record on September 4, 2026. Together, the earnings improvement, extensive buyback completion, and continued cash dividend highlight management’s focus on returning...

Why Robert Half Stock Is Back in Focus After Q2 Results Robert Half (RHI) is back on investors’ radar after its second quarter earnings and fresh third quarter guidance, which together highlighted ongoing pressure in Protiviti and steadier trends in the Talent Solutions business. See our latest analysis for Robert Half. The recent Q2 report and Q3 2026 guidance appear to have reset expectations around Protiviti’s regulatory headwinds and steadier Talent Solutions trends. Robert Half’s share...

Americold Realty Trust Stock Performance Snapshot Americold Realty Trust (COLD) has drawn attention after recent share price weakness, with the stock down 2.6% on the day and about 12% over the past month, despite a gain over the past 3 months. For readers tracking longer horizons, Americold Realty Trust shows a year to date gain of 8.9%, while the 1 year total return is down 3.8%. Over 3 and 5 years, total returns are also lower, indicating a challenging period for longer term holders. The...

In the past week, BrightSpring Health Services, Inc. reported second-quarter 2026 results showing revenue rising to US$3.87 billion and net income increasing to US$84.29 million, alongside higher earnings per share compared with a year earlier. At the same time, the company raised its full-year 2026 revenue guidance to a range of US$15.10 billion to US$15.43 billion, signaling management confidence in continued growth. Now we’ll examine how this upgraded full-year revenue guidance reshapes...

Stepan Company recently reported past second-quarter 2026 results showing sales of US$684.11 million and net income of US$22.91 million, while also affirming a quarterly dividend of US$0.395 per share. Despite stronger second-quarter earnings versus the prior year, the company reported a six-month net loss of US$18.5 million, highlighting a mixed year-to-date picture. Against this backdrop of improved quarterly profitability and a maintained dividend, we’ll examine how these developments may...

What Comstock Resources' latest earnings mean for shareholders Comstock Resources (CRK) has released second quarter 2026 results, giving investors a fresh look at how the Haynesville focused gas producer is performing across revenue, profit and production volumes. The company reported second quarter revenue of US$353.28 million compared with US$470.26 million a year earlier, and net income of US$8.77 million compared with US$124.84 million. Basic and diluted earnings per share from continuing...

Church & Dwight (CHD) is back in focus after releasing second quarter 2026 results alongside updated guidance, including modestly higher full year sales and earnings expectations plus fresh commentary on portfolio changes affecting upcoming quarterly revenue. See our latest analysis for Church & Dwight. The earnings beat and raised full year guidance have come alongside steady gains in Church & Dwight’s share price, with a 19.57% year to date share price return and a 25.59% five year total...

A. O. Smith reported its second-quarter 2026 results with sales of US$1,004.3 million and net income of US$124.9 million, alongside updated full-year guidance calling for net sales of US$3.90–3.95 billion and diluted EPS of US$3.60–3.75. The company’s continued share repurchases and focus on North American boiler strength contrasted with weaker China performance and softer residential water heater demand, shaping how investors assess its earnings quality. Next, we’ll examine how weaker China...

In July 2026, Celldex Therapeutics reported topline results from its Phase 2 clinical trial in prurigo nodularis, marking an important milestone for this program in a challenging chronic skin disease. This update is particularly important because it helps clarify the clinical trajectory of Celldex’s dermatology pipeline, a key area of focus for the company’s development efforts. We’ll now examine how the Phase 2 prurigo nodularis results could influence Celldex Therapeutics’ investment...

Kilroy Realty (KRC) is back in focus after second quarter 2026 results showed lower sales and net income versus a year earlier, while management reaffirmed full year earnings guidance and outlined a disciplined acquisition approach. See our latest analysis for Kilroy Realty. The recent second quarter report, guidance reaffirmation, acquisition commentary and ESOP related shelf registration have coincided with mixed momentum in Kilroy Realty’s stock, with a 15.4% 90 day share price return and...

e.l.f. Beauty (ELF) is back in focus for investors after recent share price moves, with the stock closing at US$82.89. The company’s multi-brand cosmetics and skin care portfolio keeps drawing attention. See our latest analysis for e.l.f. Beauty. Across recent timeframes, e.l.f. Beauty’s share price has shown strong momentum, with a 7-day share price return of 7.15% and a 90-day share price return of 37.03%, even though the 1-year total shareholder return declined 28.8%. If you are looking...

Recently, analysts upgraded China Yuchai International to a top Zacks Rank, citing a stronger projected earnings outlook and a trend of higher earnings estimates, bringing fresh attention to the company. An interesting angle is that this improved outlook comes alongside concerns about rising research and development spending and possible regulatory headwinds, which could influence how investors weigh growth against risk. Next, we’ll examine how this upgraded earnings outlook may reshape...